Research article
Matrix to predict rapid radiographic progression of early rheumatoid arthritis patients from the community treated with methotrexate or leflunomide: results from the ESPOIR cohort
1 Université Pierre et Marie Curie (UPMC) - Paris 6, GRC-08 EEMOIS; AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology, 75013 Paris, France
2 Montpellier I University; Department of Rheumatology, Lapeyronie Hospital, UMR 5535, 34000 Montpellier, France
3 Brest University; Department of Rheumatology, La Cavale Blanche University Hospital, 29000 Brest, France
4 Lorraine University, Paris-Descartes University, EA 4360 APEMAC -- Inserm, CIC-EC CIE6, CHU de Brabois, 54505 Vandoeuvre-lès-Nancy, France
5 Rheumatology Department, Rouen University Hospital & INSERM U905, Institute for Research and Innovation in Biomedicine, Rouen University; 76031 Rouen, France
Arthritis Research & Therapy 2012, 14:R249 doi:10.1186/ar4092
Published: 19 November 2012Additional files
Additional file 1:
Supplemental figures. Figure S1: Cumulative plot of the vSHS score variation between baseline and month 12. Figure S2: Fit of the final model estimated by receiver operating characteristic curve analysis. Figure S3: Observed patient frequencies in the different cells of the ESPOIR matrix.
Format: DOC Size: 952KB Download file
This file can be viewed with: Microsoft Word Viewer
